Adenosine Triphosphate(ATP)
Product Name: Adenosine Triphosphate(ATP)
Synonyms: 5-ATP-Na2; Adenosine-5-triphosphate disodium salt hydrate; 5Adenosinetriphosphoric acid disodium salt; ATP disodium salt; adenosine, 5'-(tetrahydrogen triphosphate), monosodium salt; adenosine, 5'-(tetrahydrogen triphosphate), sodium salt (1:2); Adenosine-5'-triphosphate,disodium salt; ATP,100mM Solution; Adenosine-5'-triphosphoric acid disodium salt
Appearance: White powder
CAS No.: 56-65-5
Package: For minimal order: 1KG/Aluminium foil bag, 5 bags in a carton . For large quantity: 25KG/Fiber Drum in net weight; 28KG/Fiber Drum in gross weight (Can be customized)

Products Description:

ATP is the abbreviation of the English name. The structure of ATP molecules can be abbreviated as AP ~ P ~ P, where A representative of adenosine, P behalf of phosphate groups, ~ represents a particular chemical bond, called the high-energy phosphate bond, high-energy phosphate bond cleavage, the large amount of energy is released out.
Pharmacological effects:
This product is a kind of coenzyme. To improve body metabolism, involved in
body fat, protein, sugar, nucleic acid and nucleotide metabolism, is also the main source of energy in the body. Apply Cell Injury enzyme decline diseases. Animal tests on this product electrophysiology of myocardial cells plays a significant role, can inhibit the slow reaction of cells in calcium influx, blocking and prolonging atrioventricular conduction before the loop, large doses can still be blocked atrioventricular Way of reentry, with enhanced role of the vagus nerve, can be used supraventricular tachycardia. 
It can be used in the disease caused by tissue injury and activity reduction of ecto enzyme , including heart failure, carditis, miocardial infarction, cerebral arteriosclersis, coronary sclerosis, progressive muscular atrophy , cerebral hemorrhage , chronic hepatitis, cirrhosis of liver and hearing handicap, etc.
Supraventricular tachycardia, heart failure, myocarditis, myocardial infarction, cerebral arteriosclerosis, coronary arteriosclerosis, acute poliomyelitis.
【Back】 【Print】
Copyright © 2013 AccoBio
Fax: +86 (0) 510 85191573
Tel: +86 (0) 510 85191572 / 85191575

Powered by InfoWuxi